دورية أكاديمية
EE15 Cost-Consequence Analysis of Ofatumumab in Comparison With Other Disease-Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
| العنوان: | EE15 Cost-Consequence Analysis of Ofatumumab in Comparison With Other Disease-Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada |
|---|---|
| المؤلفون: | Farhane, F, Bhan, V, Clift, F, Baharnoori, M, Thomas, K, Patel, BP, Blanchette, F, Adlard, NE, Vudumula, U, Gudala, K, Dutta, N, Grima, D, Mouallif, S |
| المصدر: | In Value in Health December 2022 25(12) Supplement:S55-S56 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2022.09.269 |